참고문헌
- Am. J. Med. v.64 no.1005 Comparison of the antihypertensive and hormonal effects of a cardioselective beta-blocker acebutolod and diuretics in essential hypertension Alhenz-Gelas, F.;Plouin, P. F.;Ducrocq, M. B.;Corvol, P. E.;Menard, J.
- Br. J. Clin. Pharmcol. v.6 no.351 Acebutolol in hypertension a double blind trial against placebo Martin, M. A.;Phillips, C. A.;Smith, A. J.
- J. Int. Med. Res. v.7 no.201 Multicentre study of a once daily dosage of acebutolol in the treatment of hypertension in general practice Baker, P. G.;Goulton, J. A.
- Br. J. Clin. Pharmacol. v.9 no.215 Pharmacokinetics of acebutolol after intravenous bolus administration Roux, A.;Flouvat, B.;Chau, N. P.;Letac, B.;Lucsko, B.
- Clin. Pharmacol. Ther. v.24 no.5 Food, splanchnic blood flow and bioavailability of drugs subject to first pass metabolism Mclean, A. J.;Mcnamara, R. J.;Souich, P. D.;Gibaldi, M.;Lalka, D.
- Eur. J. Pharmacol. v.80 no.47 Pharmacological properties of diacetolol, a major metabolite of acebutolol Basil, J.;Jordan, R.
- Br. J. Clin. Pharmacol. v.9 no.215 Pharmacokinetics of acebutolol after intravenous bolus administration Roux, A.;Flouvat, B.;Chau, N. P.;Letac, B.;Luckso, M.
- Eur. J. Clin. Pharmacol. v.31 no.643 Pharmacokinetics and bioavailability of diacetolol, the main matabolite of acebutolol Flouvat, B.;Roux, A.;Chau, N. P.
- J. Pharm. Phatmacol. v.31 no.643 Elimination of drugs by active intestinal transport George, C. F.;Gruchy, B. S.
- Biopharm. Drug Dispos. v.2 no.103 The Pharmacokinetics of acebutolol in man, following the oral administration of acebutolol as a single dose and during and after repeated oral dosing Gulaid, A. A.;James, I. M.;Kaye, C. M.
- J. Pharm. Pharmacol. v.33 no.386 Preliminary observations on the excretion of acebutolol and its acetyl matabolite in the urine and feces of man Gabriel, R.;Kaye, C. M.;Sankey, M. G.
- Biopharm. Drug Dispos. v.3 no.47 The effect of hydralazine on the pharm-acokinetics of three different beta-adrenoceptor antagonists: metoprololol, nadolol, and acebutolol Jack, D. B.;Kendall, M. J.;Dean, S.;Laugher, S. J.;Zaman, R.
- J. Cardio. Pharm. v.3 no.403 Sulfinpyrazone dose not alter the pharmacokinetics of acebutolol Patard, O.;Mier, F.;Carbon, C.;Roux, A.;Flouvat, B.
- Biopharm. Drug Dispos. v.5 no.91 The effect of food and alcohol on the pharm-acokinestics of acebutolol and its metabolite, diacetolol Zaman, B.;Wilkins, M. R.;Kendall, M. J.;Jack, D. B.
- J. Chromatogr. v.230 no.438 High performance liquid chromatography assay of acebutolol and its metabolites in plasma and urine Buskin, J. N.;Upton, R. A.;Jones, R.;Williams, R. L.
- Computer Programs in Biomedicine v.16 no.203 LAGRAN program for area and moments in pharmacokinetic analysis Rocci, M. L.;Jusko, W. J.
- Cardiovasc. Drugs Ther. v.10 no.Suppl3,869 Pharmacological aspects of calcium channel blockers Scholz, H.
- Am. J. Kidney Dis. v.16 no.Suppl 1,10 Effects of calcium antagonists on renal hemodynamics Epstein, M.
- Clin. Pharmacol. Ther. v.40 no.140 Diltiazem treatment impairs hepatic drug oxidation of antipyrine Carrum, G.;Eagam, J. M.;Abemethy, D. R.
- Clin. Pharmacol. Ther. v.44 no.29 Effect of calcium channel blockers on theophylline disposition Susan, M. S.;John, A. P.;Timothy, H. S.
- Clin. Pharmacol. Ther. v.46 no.668 The effect of diltiazem on the disposition of encainide and its active metabolites Kazierad, D. J.;Richard, L. L.;Michael, B.
- Clin. Pharmacol. Ther. v.38 no.667 Effects of verapamil, diltiazen, and nifedipine on plasma levels and renal excretion of digitoxin Kuhlmann, J.
- Clin. Pharmcol. Ther. v.46 no.469 Synergistic adverse hemodynamic interation between oral verapamil and propranolol Carruthers, G.;David, J. F.;David, G. B.
- Clin. Pharmacol. Ther. v.37 no.150 Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta-acetyldigoxin Kuhlmann, J.
- Kor. J. Clin. Pharm. v.3 no.139 Pharmacokinetics of phenytoin in rabbits pretreated with diltiazem Park, J. M.;Lee, J. H.;Choi, J. S.;Burm, J. P.